Assurant Financial Statements (AIZ)
|
|
Report date
|
|
|
19.02.2021 |
22.02.2022 |
31.12.2022 |
17.02.2023 |
15.02.2024 |
|
07.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
9 593 |
10 188 |
10 193 |
10 193 |
11 132 |
|
11 740 |
Operating Income, bln rub |
|
|
502.2 |
1 542 |
0.000 |
458.2 |
642.5 |
|
730.7 |
EBITDA, bln rub |
? |
|
19 999 |
1 046 |
458.2 |
639.0 |
1 122 |
|
1 149 |
Net profit, bln rub |
? |
|
440.8 |
613.5 |
276.6 |
276.6 |
642.5 |
|
692.7 |
|
OCF, bln rub |
? |
|
1 342 |
781.7 |
|
596.9 |
1 138 |
|
1 230 |
CAPEX, bln rub |
? |
|
121.2 |
187.4 |
|
186.3 |
202.5 |
|
212.4 |
FCF, bln rub |
? |
|
1 221 |
594.3 |
|
410.6 |
935.6 |
|
1 230 |
Dividend payout, bln rub
|
|
|
173.3 |
162.3 |
|
150.2 |
152.3 |
|
114.8 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
39.3% |
26.5% |
0.00% |
54.3% |
23.7% |
|
16.6% |
|
OPEX, bln rub |
|
|
9 091 |
8 646 |
0.000 |
7 366 |
7 695 |
|
7 932 |
Cost of production, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
104.5 |
111.8 |
108.3 |
108.3 |
108.0 |
|
106.9 |
|
Assets, bln rub |
|
|
44 650 |
33 912 |
33 124 |
33 124 |
33 635 |
|
35 332 |
Net Assets, bln rub |
? |
|
5 951 |
5 490 |
4 229 |
4 229 |
4 810 |
|
5 255 |
Debt, bln rub |
|
|
2 253 |
2 203 |
2 130 |
2 130 |
2 080 |
|
2 083 |
Cash, bln rub |
|
|
16 011 |
9 504 |
0.000 |
7 976 |
8 540 |
|
9 410 |
Net debt, bln rub |
|
|
-13 758 |
-7 301 |
2 130 |
-5 846 |
-6 459 |
|
-7 327 |
|
Ordinary share price, rub |
|
|
136.2 |
155.9 |
125.1 |
125.1 |
168.5 |
|
163.8 |
Number of ordinary shares, mln |
|
|
60.1 |
59.1 |
54.4 |
54.4 |
53.5 |
|
52.2 |
|
Market cap, bln rub |
|
|
8 189 |
9 218 |
6 800 |
6 800 |
9 007 |
|
8 552 |
EV, bln rub |
? |
|
-5 569 |
1 916 |
8 930 |
954 |
2 548 |
|
1 225 |
Book value, bln rub |
|
|
2 206 |
2 335 |
1 363 |
1 363 |
1 634 |
|
2 073 |
|
EPS, rub |
? |
|
7.33 |
10.4 |
5.09 |
5.09 |
12.0 |
|
13.3 |
FCF/share, rub |
|
|
20.3 |
10.0 |
0.00 |
7.55 |
17.5 |
|
23.6 |
BV/share, rub |
|
|
36.7 |
39.5 |
25.1 |
25.1 |
30.6 |
|
39.7 |
|
EBITDA margin, % |
? |
|
208.5% |
10.3% |
4.50% |
6.27% |
10.1% |
|
9.78% |
Net margin, % |
? |
|
4.59% |
6.02% |
2.71% |
2.71% |
5.77% |
|
5.90% |
FCF yield, % |
? |
|
14.9% |
6.45% |
0.00% |
6.04% |
10.4% |
|
14.4% |
ROE, % |
? |
|
7.41% |
11.2% |
6.54% |
6.54% |
13.4% |
|
13.2% |
ROA, % |
? |
|
0.99% |
1.81% |
0.84% |
0.84% |
1.91% |
|
1.96% |
|
P/E |
? |
|
18.6 |
15.0 |
24.6 |
24.6 |
14.0 |
|
12.3 |
P/FCF |
|
|
6.71 |
15.5 |
|
16.6 |
9.63 |
|
6.95 |
P/S |
? |
|
0.85 |
0.90 |
0.67 |
0.67 |
0.81 |
|
0.73 |
P/BV |
? |
|
3.71 |
3.95 |
4.99 |
4.99 |
5.51 |
|
4.13 |
EV/EBITDA |
? |
|
-0.28 |
1.83 |
19.5 |
1.49 |
2.27 |
|
1.07 |
Debt/EBITDA |
|
|
-0.69 |
-6.98 |
4.65 |
-9.15 |
-5.76 |
|
-6.38 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
1.26% |
1.84% |
0.00% |
1.83% |
1.82% |
|
1.81% |
|
Assurant shareholders |